Elicio Therapeutics, Inc. (ELTX)
NASDAQ: ELTX · Real-Time Price · USD
8.00
-0.33 (-3.96%)
At close: Dec 5, 2025, 4:00 PM EST
8.42
+0.42 (5.25%)
After-hours: Dec 5, 2025, 4:46 PM EST
Elicio Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 140 | 55 | 80 | - | - | - | |
| Market Cap Growth | 145.22% | -31.39% | - | - | - | - | |
| Enterprise Value | 134 | 55 | 72 | - | - | - | |
| Last Close Price | 8.00 | 5.10 | 8.34 | - | - | - | |
| PB Ratio | 36.18 | -4.86 | 7.04 | - | - | - | |
| P/TBV Ratio | 36.64 | - | 7.04 | - | - | - | |
| Debt / Equity Ratio | 3.95 | -2.30 | 0.61 | 0.84 | -2.88 | 0.03 | |
| Quick Ratio | 3.16 | 1.53 | 1.32 | 0.90 | 0.49 | 4.53 | |
| Current Ratio | 3.30 | 1.80 | 1.68 | 1.56 | 0.55 | 4.67 | |
| Return on Equity (ROE) | - | -170157.38% | -346.95% | -1170.93% | -430.76% | -136.60% | |
| Return on Assets (ROA) | -79.40% | -101.64% | -89.70% | -79.16% | -92.36% | -68.96% | |
| Return on Capital (ROIC) | -204.09% | -170.31% | -128.82% | -123.12% | -130.00% | -80.83% | |
| Return on Capital Employed (ROCE) | -194.50% | -270.10% | -205.50% | -150.20% | 626.30% | -96.10% | |
| Earnings Yield | -32.80% | -94.42% | -43.93% | - | - | - | |
| FCF Yield | -27.86% | -67.60% | -40.89% | - | - | - | |
| Buyback Yield / Dilution | -35.90% | -141.35% | -1500.08% | 97.93% | -42.39% | -172.21% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.